| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/20/2011 | EP2344128A2 Ophthalmic administration of a composition including brimonidine as a mist |
| 07/20/2011 | EP1317279B1 Vaccine against streptococcus pneumoniae |
| 07/20/2011 | EP1218007B1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 07/20/2011 | CN1944448B Puerarin derivative and its medicinal use |
| 07/20/2011 | CN1883469B An ocular microemulsion containing Vitamin A and Vitamin E and preparation method thereof |
| 07/20/2011 | CN102131821A Glucocorticoids attached to nitrate esters via aromatic linker in position 21 and their use in ophthalmology |
| 07/20/2011 | CN102131803A Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 07/20/2011 | CN102131784A Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 07/20/2011 | CN102131782A Pyridine derivatives as VEGF-2 receptor and protein tyrosine kinase inhibitors |
| 07/20/2011 | CN102131774A Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 07/20/2011 | CN102127071A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127023A 7-membered ring compound, process for producing the same, and use thereof |
| 07/20/2011 | CN102125136A Nose-throat-ear medicinal tea |
| 07/20/2011 | CN101695530B Medicament for treating myopia and preparation method thereof |
| 07/20/2011 | CN101560201B Technique for extracting puerarin and diverse medical ingredients from root of kudzuvine |
| 07/20/2011 | CN101245106B Anti-VRGF acceptor monoclone antibody, preparation method and application thereof |
| 07/19/2011 | USRE42562 EP4 receptor agonist, compositions and methods thereof |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2565944C Stabilized hyaluronan preparations and related methods |
| 07/19/2011 | CA2485677C Methods of treating allergic reactions |
| 07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2432464C Excitatory amino acid receptor antagonists |
| 07/19/2011 | CA2431606C Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/14/2011 | WO2011085361A1 Combination, kit and method of reducing intraocular pressure |
| 07/14/2011 | WO2011085209A2 Methods and compositions for applying moxifloxacin to the ear |
| 07/14/2011 | WO2011085155A2 Formulations and methods for dissolving cerumen |
| 07/14/2011 | WO2011084366A2 Methods, compositions and drug delivery systems for intraocular delivery of sirna molecules |
| 07/14/2011 | WO2011082488A1 Bisphenol derivative therapeutics and methods for their use |
| 07/14/2011 | US20110172313 Image quality in the eye |
| 07/14/2011 | US20110172302 Methods of treating meibomian gland dysfunction |
| 07/14/2011 | US20110172299 Therapeutic substituted cyclopentanes |
| 07/14/2011 | US20110172297 Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions Thereof |
| 07/14/2011 | US20110172292 Antidote oligomers |
| 07/14/2011 | US20110172279 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/14/2011 | US20110172266 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/14/2011 | US20110172265 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 07/14/2011 | US20110172250 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists |
| 07/14/2011 | US20110172244 Compounds and compositions as modulators of gpr119 activity |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172229 Modulators of atp-binding cassette transporters |
| 07/14/2011 | US20110172206 Compositions and methods for treatment of neurodegenerative disease |
| 07/14/2011 | US20110172195 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| 07/14/2011 | US20110172186 Inhibitors of fatty acid amide hydrolase |
| 07/14/2011 | US20110172177 Combination, kit and method of reducing intraocular pressure |
| 07/14/2011 | US20110172164 Bi-dentate compounds as kinase inhibitors |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110171307 Methods and products for treatment of diseases |
| 07/14/2011 | US20110171306 Methods and products for treatment of diseases |
| 07/14/2011 | US20110171275 Gastroretentive drug delivery system, preparation method and use thereof |
| 07/14/2011 | US20110171202 Method of treating hearing loss using xiap |
| 07/14/2011 | US20110171190 Pharmacological vitreolysis |
| 07/14/2011 | US20110171130 A3 adenosine receptor antagonists and partial agonists |
| 07/14/2011 | CA2786525A1 Methods and compositions for applying moxifloxacin to the ear |
| 07/14/2011 | CA2784908A1 Combination, kit and method of reducing intraocular pressure |
| 07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 07/13/2011 | EP2342203A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/13/2011 | EP1758552B1 Intraocular implants of alpha-2 adrenergic receptor agonists for preventing or reducing ocular vascular occlusions |
| 07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 07/13/2011 | EP1432420B1 Benzimidazolidinone derivatives as muscarinic agents |
| 07/13/2011 | EP1265878B1 A process for the preparation of epothilone analogs and intermediates |
| 07/13/2011 | CN102123727A Compounds for treating beta-amyloidoses |
| 07/13/2011 | CN102123713A Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
| 07/13/2011 | CN102123709A A3 adenosine receptor allosteric modulators |
| 07/13/2011 | CN102123703A 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus |
| 07/13/2011 | CN102121023A Mutant human plasminogen kringle5, preparation method and application thereof |
| 07/13/2011 | CN102120724A 5-amino-4-hydroxy-7-benzyl-8-methylnonanamide derivative, preparation method thereof and application thereof in medicines |
| 07/13/2011 | CN102119938A Folk Chinese herb medicine fruiting eight trigram-shaped maple root wine |
| 07/13/2011 | CN102119932A Ophthalmic composition for silicone hydrogel contact lenses |
| 07/13/2011 | CN102119916A Liquid oxygen in-situ forming gel and preparation method and application thereof |
| 07/13/2011 | CN102119821A Health-protecting material, application thereof in preparing health-protecting pillow and cushion, and health-protecting pillow and cushion |
| 07/13/2011 | CN101282926B S1p3 receptor antagonist |
| 07/13/2011 | CN101166742B Novel lactam compound |
| 07/12/2011 | US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders |
| 07/12/2011 | US7977387 Aminobenzophenone compounds |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | US7975690 Nasal devices |
| 07/12/2011 | CA2499492C Methods of preparing cannabinoids from plant material |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2480266C Use of an alpha2-adrenoreceptor antagonist for cns-related diseases |
| 07/12/2011 | CA2470721C Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2389685C Novel heterocyclic compounds and their use as medicaments |
| 07/07/2011 | WO2011081383A2 Composition including naphthoquinone compound for treating and preventing hearing loss |
| 07/07/2011 | WO2011081221A1 Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | WO2011080984A1 Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction |
| 07/07/2011 | WO2011079841A1 Beta-carbolines for use in the treatment of hearing loss and vertigo |
| 07/07/2011 | WO2011028797A3 Treatment of glaucoma and other retinopathies with gangliosides |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110166209 Compositions and methods for ameliorating myosin viia defects |
| 07/07/2011 | US20110166190 Methods of treating mammals with eustachian tube dysfunctions |
| 07/07/2011 | US20110166176 Compounds and compositions as modulators of gpr119 activity |
| 07/07/2011 | US20110166175 7-azaindole derivatives |
| 07/07/2011 | US20110166174 Compounds modulating c-kit and c-fms activity and uses therefor |
| 07/07/2011 | US20110166161 Heterocyclic carboxamide compounds |
| 07/07/2011 | US20110166146 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS |
| 07/07/2011 | US20110166126 Compositions and Methods for Modulating Endophthalmitis Using Fluoroquinolones |
| 07/07/2011 | US20110166124 Tricyclic spirocycle derivatives and methods of use |